华特达因(000915) - 2017 Q3 - 季度财报

Financial Performance - Operating revenue for the current period reached CNY 481,913,056.26, a 26.18% increase year-on-year[5] - Net profit attributable to shareholders increased by 29.58% to CNY 69,505,393.31 compared to the same period last year[5] - Basic earnings per share rose by 30.43% to CNY 0.30[5] - The net profit attributable to the parent company increased by 35.55% to RMB 216,237,657.04, mainly due to the increase in net profit from pharmaceutical products[17] - Investment income surged by 161.02% to RMB 2,470,849.27, attributed to the returns from bank financial products purchased by the company[15] Assets and Liabilities - Total assets increased by 14.13% to CNY 2,832,852,419.50 compared to the end of the previous year[5] - Net assets attributable to shareholders increased by 14.67% to CNY 1,472,343,478.59 compared to the end of the previous year[5] - Accounts receivable rose by 33.22% to RMB 254,750,798.62, primarily due to an increase in receivables from sales[15] - Other payables rose by 87.96% to RMB 119,267,909.25, primarily due to an increase in unpaid sales expenses[15] - The company’s total liabilities decreased significantly, with accounts payable dropping by 86.34% to RMB 4,752,021.21, due to the payment of matured bank acceptance bills[15] Cash Flow - Cash flow from operating activities decreased by 25.31% to CNY 267,731,595.48 year-to-date[5] - Cash received from investment increased by 85.61% to RMB 278,050,000.00, mainly due to the recovery of bank financial products[17] Shareholder Information - The total number of shareholders at the end of the reporting period was 17,560[10] - The largest shareholder, Shandong University Industry Group Co., Ltd., holds 20.72% of the shares[10] - No repurchase transactions were conducted by the top 10 shareholders during the reporting period[12] Expenses - Sales expenses increased by 45.05% to RMB 338,459,360.27, corresponding to the rise in operating income[15] - The company’s total tax expenses increased by 42.51% to RMB 69,205,727.50, reflecting the growth in total profit for the period[15] - The company’s cash paid for employee compensation increased by 31.04% to RMB 198,017,282.78, due to higher salary payments[17] - The company’s financial expenses decreased by 72.44% to RMB 5,067,706.49, mainly due to a reduction in cash discounts[15] Non-Recurring Items - The company has not reclassified any non-recurring gains and losses as recurring[8]